title: From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs).
abstract: Our understanding of the molecular mechanisms underlying the pharmacological actions of estrogen receptor (ER) ligands has evolved considerably in recent years. Much of this knowledge has come from a detailed dissection of the mechanism(s) of action of the Selective Estrogen Receptor Modulators (SERMs) tamoxifen and raloxifene, drugs whose estrogen receptor (ER) agonist/antagonist properties are influenced by the cell context in which they operate. These studies have revealed that notwithstanding differences in drug pharmacokinetics, the activity of an ER ligand is determined primarily by (a) the impact that a given ligand has on the receptor conformation and (b) the ability of structurally distinct ER-ligand complexes to interact with functionally distinct coregulators. Exploitation of the established relationships between ER structure and activity has led to the development of improved SERMs with more favorable therapeutic properties and of tissue-selective estrogen complexes, drugs in which a SERM and an ER agonist are combined to yield a blended activity that results in distinct clinical profiles. Remarkably, endogenous ligands that exhibit SERM activity have also been identified. One of these ligands, 27-hydroxycholesterol (27HC), has been shown to manifest ER-dependent pathological activities in the cardiovascular system, bone and mammary gland. Whereas the physiological activity of 27HC remains to be determined, its discovery highlights how cells have adopted mechanisms to allow the same receptor ligand complex to manifest different activities in different cells, and also how these processes can be exploited for new drug development.
authors.affiliation: Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, United States.
authors.forename: Suzanne E
authors.initials: SE
authors.lastname: Wardell
authors.affiliation: Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, United States. Electronic address: enels@illinois.edu.
authors.forename: Erik R
authors.initials: ER
authors.lastname: Nelson
authors.affiliation: Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, United States. Electronic address: donald.mcdonnell@duke.edu.
authors.forename: Donald P
authors.initials: DP
authors.lastname: McDonnell
mesh_terms: D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects / Q000378:metabolism; D047628:Estrogen Receptor alpha / Q000378:metabolism; D006801:Humans; D006888:Hydroxycholesterols / Q000378:metabolism; D042361:Mammary Glands, Human / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology*; D013629:Tamoxifen / Q000494:pharmacology
chemical_list: D047628:Estrogen Receptor alpha; D006888:Hydroxycholesterols; D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; C076996:27-hydroxycholesterol
keywords: Estrogen receptor; SERM; Selective estrogen receptor modulator; TSEC; Tamoxifen
references.citation: J Clin Endocrinol Metab. 2009 Jul;94(7):2284-9
references.pmid: 19351734
references.citation: Menopause. 2011 Jan;18(1):17-22
references.pmid: 20689465
references.citation: Endocrinology. 1999 Dec;140(12):5566-78
references.pmid: 10579320
references.citation: Life Sci. 1980 Apr 28;26(17):1453-8
references.pmid: 7382727
references.citation: Eur J Epidemiol. 2004;19(12):1105-12
references.pmid: 15678790
references.citation: Endocrinology. 1999 Dec;140(12):5828-40
references.pmid: 10579349
references.citation: Breast Cancer Res Treat. 2012 Jul;134(1):299-306
references.pmid: 22484799
references.citation: Maturitas. 2014 Jun;78(2):91-8
references.pmid: 24679891
references.citation: Cancer Res. 2007 Oct 1;67(19):9549-60
references.pmid: 17909066
references.citation: J Clin Endocrinol Metab. 2014 Feb;99(2):E189-98
references.pmid: 24438370
references.citation: JAMA. 1999 Aug 18;282(7):637-45
references.pmid: 10517716
references.citation: JAMA. 2006 Jun 21;295(23):2727-41
references.pmid: 16754727
references.citation: Cell Rep. 2013 Nov 14;5(3):637-45
references.pmid: 24210818
references.citation: Mol Endocrinol. 1995 Jun;9(6):659-69
references.pmid: 8592512
references.citation: Nat Chem Biol. 2010 Nov;6(11):837-43
references.pmid: 20924370
references.citation: Menopause. 2007 May-Jun;14(3 Pt 1):510-7
references.pmid: 17314736
references.citation: Endocrinology. 1994 Nov;135(5):2001-5
references.pmid: 7956922
references.citation: Br Med J. 1977 May 21;1(6072):1351-2
references.pmid: 861624
references.citation: Circulation. 2001 Jan 23;103(3):423-8
references.pmid: 11157695
references.citation: N Engl J Med. 2010 Feb 25;362(8):686-96
references.pmid: 20181970
references.citation: Climacteric. 2011 Feb;14(1):105-11
references.pmid: 20839957
references.citation: Science. 1999 Jul 30;285(5428):744-6
references.pmid: 10426998
references.citation: J Natl Cancer Inst. 2010 Nov 17;102(22):1706-15
references.pmid: 21051656
references.citation: Mol Endocrinol. 1999 Nov;13(11):1912-23
references.pmid: 10551784
references.citation: Endocrinology. 2010 Aug;151(8):3675-85
references.pmid: 20501668
references.citation: Cancer Res. 2001 Apr 1;61(7):2917-22
references.pmid: 11306468
references.citation: JAMA. 2002 Jul 17;288(3):321-33
references.pmid: 12117397
references.citation: Menopause. 2006 May-Jun;13(3):377-86
references.pmid: 16735934
references.citation: Lancet. 2003 Aug 9;362(9382):419-27
references.pmid: 12927427
references.citation: J Clin Oncol. 2008 Apr 1;26(10):1664-70
references.pmid: 18316794
references.citation: Mol Endocrinol. 2002 Mar;16(3):469-86
references.pmid: 11875105
references.citation: Nature. 1966 Oct 1;212(5057):87
references.pmid: 5965580
references.citation: Anal Biochem. 1995 Feb 10;225(1):73-80
references.pmid: 7778789
references.citation: J Clin Oncol. 2009 Dec 20;27(36):6135-43
references.pmid: 19901118
references.citation: Gynecol Oncol. 2003 Jul;90(1):64-9
references.pmid: 12821343
references.citation: Osteoporos Int. 2012 Mar;23(3):1091-101
references.pmid: 21374068
references.citation: Cancer Res. 1988 Sep 15;48(18):5183-7
references.pmid: 3409244
references.citation: Fertil Steril. 2009 Sep;92(3):1039-1044
references.pmid: 19635614
references.citation: Atherosclerosis. 2011 Feb;214(2):448-55
references.pmid: 21130455
references.citation: Clin Cancer Res. 2002 Jun;8(6):1995-2001
references.pmid: 12060645
references.citation: Cancer Prev Res (Phila). 2010 Jun;3(6):696-706
references.pmid: 20404000
references.citation: J Bone Miner Res. 2008 Dec;23(12):1923-34
references.pmid: 18665787
references.citation: J Bone Miner Res. 2008 Apr;23(4):525-35
references.pmid: 18072873
references.citation: Lancet Oncol. 2012 May;13(5):476-86
references.pmid: 22401913
references.citation: J Med Chem. 2001 May 24;44(11):1654-7
references.pmid: 11356100
references.citation: Breast Cancer Res Treat. 1987 Oct;10(1):31-5
references.pmid: 3689979
references.citation: Curr Pharm Des. 2002;8(23):2089-111
references.pmid: 12171520
references.citation: Clin Cancer Res. 2013 May 1;19(9):2420-31
references.pmid: 23536434
references.citation: Nat Med. 2007 Oct;13(10):1185-92
references.pmid: 17873880
references.citation: Gend Med. 2011 Apr;8(2):57-68
references.pmid: 21536225
references.citation: J Natl Cancer Inst. 2003 Mar 5;95(5):353-61
references.pmid: 12618500
references.citation: Nature. 1997 Oct 16;389(6652):753-8
references.pmid: 9338790
references.citation: Menopause. 2009 Nov-Dec;16(6):1193-6
references.pmid: 19503006
references.citation: Biol Reprod. 2014 Jun;90(6):121
references.pmid: 24740602
references.citation: Menopause. 2013 Feb;20(2):138-45
references.pmid: 23271189
references.citation: J Bone Miner Metab. 2006;24(4):314-8
references.pmid: 16816926
references.citation: Metabolism. 2004 Jun;53(6):744-8
references.pmid: 15164322
references.citation: Endocrinology. 2000 Feb;141(2):809-20
references.pmid: 10650964
references.citation: Menopause. 2004 Mar-Apr;11(2):167-75
references.pmid: 15021446
references.citation: Science. 1995 Nov 24;270(5240):1354-7
references.pmid: 7481822
references.citation: Menopause. 2009 Sep-Oct;16(5):1061-4
references.pmid: 19369903
references.citation: Cell. 1998 Dec 23;95(7):927-37
references.pmid: 9875847
references.citation: Cancer Res. 1987 Jan 15;47(2):624-30
references.pmid: 3098415
references.citation: Gynecol Endocrinol. 2004 Mar;18(3):152-8
references.pmid: 15255284
references.citation: J Clin Invest. 1994 Jan;93(1):63-9
references.pmid: 8282823
references.citation: Science. 2013 Nov 29;342(6162):1094-8
references.pmid: 24288332
references.citation: Endocrinology. 1997 Mar;138(3):863-70
references.pmid: 9048584
references.citation: Mol Endocrinol. 1997 Jun;11(6):657-66
references.pmid: 9171229
references.citation: Arch Intern Med. 2004 Jan 26;164(2):146-52
references.pmid: 14744837
references.citation: Clin Cancer Res. 2009 Mar 15;15(6):2098-106
references.pmid: 19276281
references.citation: Am J Public Health. 2013 Sep;103(9):1583-8
references.pmid: 23865654
references.citation: Endocrinology. 1997 Sep;138(9):3901-11
references.pmid: 9275080
references.citation: Menopause. 2013 May;20(5):518-24
references.pmid: 23403500
references.citation: J Bone Miner Res. 1987 Oct;2(5):449-56
references.pmid: 3455628
references.citation: J Natl Cancer Inst. 1989 Jul 19;81(14):1086-8
references.pmid: 2738937
references.citation: N Engl J Med. 1992 Mar 26;326(13):852-6
references.pmid: 1542321
references.citation: Mol Cell. 2005 May 13;18(4):413-24
references.pmid: 15893725
references.citation: BMC Musculoskelet Disord. 2010 Jun 22;11:130
references.pmid: 20569451
references.citation: Mol Pharmacol. 2011 Oct;80(4):610-20
references.pmid: 21737572
references.citation: Mol Cell Biol. 1999 Dec;19(12):8226-39
references.pmid: 10567548
references.citation: Endocr Rev. 2004 Feb;25(1):45-71
references.pmid: 14769827
references.citation: Science. 1997 Aug 15;277(5328):965-8
references.pmid: 9252329
references.citation: Endocrinology. 2004 Jan;145(1):149-60
references.pmid: 14500565
references.citation: Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10563-7
references.pmid: 1438251
references.citation: J Clin Oncol. 2010 Oct 20;28(30):4594-600
references.pmid: 20855825
references.citation: Mol Endocrinol. 2008 Jan;22(1):65-77
references.pmid: 17872378
references.citation: Cancer. 1984 Feb 15;53(4):853-7
references.pmid: 6692287
references.citation: Maturitas. 2002 Nov 20;43(3):207-14
references.pmid: 12443837
references.citation: Mol Endocrinol. 2006 Dec;20(12):3120-32
references.pmid: 16945990
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jan 15;877(3):261-8
references.pmid: 19121981
references.citation: Nucleic Acids Res. 1991 Dec 11;19(23):6595-602
references.pmid: 1754396
references.citation: J Endocrinol. 1980 Jun;85(3):519-24
references.pmid: 7411013
references.citation: Cancer Res. 1988 Feb 15;48(4):812-5
references.pmid: 3338079
references.citation: Int J Cancer. 2011 Jan 1;128(1):144-56
references.pmid: 20232395
references.citation: Mol Pharmacol. 1998 Jul;54(1):105-12
references.pmid: 9658195
references.citation: Oncology. 1988;45(5):344-5
references.pmid: 3412740
references.citation: Endocr J. 2002 Apr;49(2):211-7
references.pmid: 12081241
references.citation: Expert Rev Anticancer Ther. 2009 Jan;9(1):51-60
references.pmid: 19105706
references.citation: Endocrinology. 2005 Sep;146(9):3999-4008
references.pmid: 15961563